FDA Warns of Heart Risk Associated with Celexa
The FDA has released a warning that high doses of Celexa have been linked to an increased risk of abnormal changes in the activity of the heart.
Dangerous Drugs
Actos Bladder Cancer Warning Released by FDA
An Actos bladder cancer FDA warning has been released announcing that use of Actos longer than a year may be linked to bladder cancer.
SSRI Birth Defect Lawyers
A study has linked the use of SSRIs to an increased risk of autism.
Biophosphonate, Fosamax Side Effects to Be Reviewed by FDA
The FDA is reviewing the side effects of Fosamax and other biophosphonates to evaluation complications reportedly associated with these medications.
Chantix Linked to Cardiovascular Events
A report indicates that the smoking cessation drug Chantix has been linked to possible cardiovascular risks.
Zoloft, SSRIs Linked to Birth Defects
Zoloft and other SSRIs have been linked to an increased risk of birth defects when taken by pregnant women.
Crestor Diabetes Linked to High Doses of the Drug: Study
Crestor Diabetes: A study has found that high doses of Crestor leads to a higher risk of developing diabetes.
Topamax Birth Defects Warning Released by FDA
Topamax birth defects announcement has been released by the FDA indicating that pregnant users of the drug are at an increased risk of delivering children with Topamax cl
Drug Use During Pregnancy On the Rise, Says Study
Zoloft birth defects lawyers comment on the increase of drug use in pregnant women.
Actos Sales Suspended in Germany, France
While an Actos recall has not been issued by the FDA, due to the Actos bladder cancer risk, sales of the drugs have been halted in Germany and France.